Atg2A Activators encompass a diverse class of chemical compounds specifically tailored to augment the function of the Atg2A protein, a critical component in the autophagy process. Atg2A is integral for the formation and elongation of autophagosomes, cellular structures that encapsulate cellular components for degradation and recycling. Activators of Atg2A enhance the autophagic flux by facilitating the lipid transfer activity that is central to Atg2A's role. These activators achieve their function by stabilizing the protein conformation that favors lipid binding and transfer, or by amplifying the interaction between Atg2A and other autophagy-related proteins, such as Atg9 and the WIPI-Atg18 complex. The precise mechanisms of action for these activators vary, but they commonly lead to an increase in the autophagosome formation rate, thus promoting the autophagic turnover. Some activators may function by increasing the availability of lipids that are necessary substrates for Atg2A's lipid transfer activity, thereby enhancing the autophagosome membrane's expansion. Others may interact with the regulatory regions of the Atg2A protein, inducing a conformational change that results in heightened activity.
The efficiency of Atg2A activators is also attributed to their ability to modulate the localization of Atg2A to the sites of autophagosome formation. By influencing the cytoskeletal dynamics or the membrane curvature within the cell, these activators can ensure that Atg2A is present at the phagophore assembly site where its activity is most needed. Additionally, Atg2A activators may indirectly support the protein's function by enhancing the upstream signaling pathways that govern autophagy induction, such as AMPK or mTOR, which in turn could lead to a cellular environment that favors autophagy. The fine-tuning of Atg2A activity through these activators is crucial, as it allows the cell to respond dynamically to varying metabolic needs and stress conditions. The enhancement of Atg2A function by these activators thus serves as a pivotal influence on the autophagic machinery, ensuring cellular homeostasis and the maintenance of a balanced proteostatic environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin binds to FKBP12 and together they inhibit mTOR, which is a negative regulator of autophagy. Inhibition of mTOR leads to the activation of Atg2A's role in autophagosome formation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits inositol monophosphatase, leading to the depletion of inositol and the inhibition of the PI3K/Akt/mTOR pathway, which in turn enhances Atg2A-mediated autophagy. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide inhibits SIRT1, which leads to the hyperacetylation of proteins and has been shown to enhance autophagy via the Atg2A pathway. | ||||||
D-(+)-Trehalose Anhydrous | 99-20-7 | sc-294151 sc-294151A sc-294151B | 1 g 25 g 100 g | $29.00 $164.00 $255.00 | 2 | |
Trehalose activates autophagy by promoting the fusion of autophagosomes with lysosomes, a process in which Atg2A is critically involved. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $32.00 $70.00 | 5 | |
Carbamazepine initiates autophagy by inhibiting inositol synthesis, thus leading to the activation of Atg2A in the autophagosome formation process. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates SIRT1, which deacetylates proteins involved in autophagy, thereby potentiating Atg2A's role in autophagosome elongation. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $56.00 $595.00 $173.00 | ||
Spermidine is known to induce autophagy through the inhibition of the acetyltransferase EP300, which enhances Atg2A activity during autophagosome development. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $42.00 $62.00 $153.00 $255.00 $500.00 $30.00 | 37 | |
Metformin activates AMPK which in turn inhibits mTOR signaling, leading to the activation of autophagy and the functional enhancement of Atg2A. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil induces autophagy by elevating cytosolic calcium levels, which is known to promote the Atg2A-dependent autophagosome-lysosome fusion process. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $46.00 $92.00 $117.00 | 3 | |
Salicylic acid induces autophagy independently of its inhibition of cyclooxygenases, potentially through the activation of AMPK, thereby enhancing Atg2A's autophagic function. |